Liver Talks: The Liver Fellow Network Podcast

Join us for a deep dive into hepatocellular carcinoma (HCC) therapy with leaders in the field: Dr. Parissa Tabrizian and Dr. Ju Dong Yang.

In this episode, we break down the modern management of HCC across disease stages, from surgical resection and locoregional therapies to systemic and immunotherapy options. Our guests walk us through real-world clinical decision-making and the nuances of multidisciplinary care in an increasingly complex treatment landscape.

We also feature a special segment at the end with Dr. Allie Cao who is the trainee lead for the HCC Special Interest Group (SIG).

Hosts:
Vlad Fomin
Dilara Hatipoglu
Adam Winters
Alex Vogel

Edited By:
Taylor Gouterman

Our first surgeon guest is here! Dr. Juan Rocca from Weill Cornell Medical Center joins us to break down living donor liver transplantation — from patient selection and surgical decision-making to the history of living donation. Plus, we can’t resist a little liver anatomy talk (yes, we have favorite segments).

Join us as we dive deep into Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with a true titan in the field: Dr. Mazen Noureddin.

Dr. Noureddin joins us from the Houston Research Institute and Houston Methodist Hospital to break down the complexities of MASLD diagnosis and the modern care pathways that are redefining hepatology. We explore the current state of pharmacologic management and insights into the Phase 2 clinical trial of Efruxifermin (and learn to pronounce it!).

We have a special guest segment with Maria Mironova, the MASLD Special Interest Group (SIG) leader at AASLD, who shares how the SIG is shaping the future of liver research and education.

Join us for a unique recording from the live podcast at AASLD 2025!
In this episode, we sit down with Dr. Kaplan (University of Pennsylvania) and Dr. Fortune (Miami Transplant Institute) to break down a challenging case. Hear how these leaders in portal hypertension think through diagnosis, management, and the nuances of portal hypertension. 
Hosts:
Vlad Fomin 
Dilara Hatipoglu
Adam Winters
Alex Vogel
Guests:
David E. Kaplan
Brett E. Fortune
Edited By:
Taylor Gouterman

Join us for an in-depth discussion on Acute-on-Chronic Liver Failure (ACLF) with Dr. Christina Lindenmeyer, board-certified transplant hepatologist at the Cleveland Clinic and founder of their groundbreaking Medical Intensive Liver Unit (MILU).

Dr. Lindenmeyer, who serves as Vice Chair of the AASLD ACLF Special Interest Group, breaks down the essential definitions and diagnostic criteria of ACLF, explores evidence-based management strategies, and shares insights from her extensive research in liver failure and transplantation.

We are excited to announce we have two new fellow hosts, Vlad Fomin and Dilara Hatipoglu! They are so excited to spend the year with you all learning about the liver. Listen to the end as we debut a brand new lightning round!

In Liver we trust.